Seroprevalence study of HTLV-1 and HIV infection in blood donors and patients with lymphoid malignancies in Lagos, Nigeria

Central African Journal of Medicine

Volumn 44, Issue 5, 1998, Pages 130-134

  Analo, H I ^a   Akanmu, A S ^a   Akinsete, I ^a   Njoku, O S ^b   Okany, C C ^a  

^a UNIVERSITY OF LAGOS   (Nigeria)

^b Military Hospital   (Nigeria)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; BLOOD DONOR; CASE CONTROL STUDY; CHRONIC LYMPHATIC LEUKEMIA; CROSS-SECTIONAL STUDY; EPIDEMIOLOGY; FEMALE; HEALTH; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; HUMAN T CELL LEUKEMIA VIRUS INFECTION; IMMUNOLOGY; MALE; MIDDLE AGED; NIGERIA; NONHODGKIN LYMPHOMA; STATISTICS;

ADOLESCENT; ADULT; BLOOD DONORS; CASE-CONTROL STUDIES; CROSS-SECTIONAL STUDIES; FEMALE; HIV SEROPREVALENCE; HTLV-I INFECTIONS; HUMANS; LEUKEMIA, LYMPHOCYTIC, CHRONIC; LYMPHOMA, NON-HODGKIN; MALE; MIDDLE AGED; NIGERIA; SEROEPIDEMIOLOGIC STUDIES; URBAN HEALTH;

EID: 0032064331     PISSN: 00089176     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Rous P. A sarcoma of the fowl transmissible by an agent separable from the tumour cells. J Exp Med 1911;13:397-411.
2. Poiesz BJ, Rusietti FW, Gazdar AF, Bunn PA, Minna JD, Gallo RC, et al. Detection and isolation of type C retrovirus particles from fresh and cultured lympocytes of a patient with cutaneous T-cell Lymphoma. Proc Natl Acad Sci (USA) 1980;77:6415-19.
3. Hinuma Y, Nagata K, Hanaoka M. Adult T-cell Leukaemia: antigen in an ATL cell line and detection of antibodies to the antigen in human sera. Proc Natl Acad Sci (USA) 1981;78:6474-80.
4. Uchiyama T, Yodoi I, Sagawa K, Takatsuki K, Uchino H, et al. Adult T-cell Leukaemia: Clinical and Haematological features of 16 cases. Blood 1977;50:481-92.
5. Kalyanaraman VS, Sarngadharan MG, Robert-Guroff, Miyoshi I, Golde D, Gallo RC, et al. A new subtype of HumanT-cell variant of Hairy Cell Leukaemia. Science 1982;218:571-3.
6. Yoshida M, Saiki M, Yamaguchi K, Takatsuki K. Monoclonal intergration of Human T-cell leukemia provirus in all primary tumours of Adult T-cell Leukemia suggests a causative role of Human T-cell Leukemia Virus in the disease. Proc Natl Acad Sci (USA) 1984;81:2534-7.
7. Osame M, Izumo S, Igata A, Matsumoto M, Matsumoto T, Sonoda S, et al. Blood transfusion and HTLV-1 associated myelopathy. Lancet 1986;2(8498):104-5.
8. Kinoshita K, Honi S, Amagasaki T, Ikeda S, Yamada Y, Suzuyama B, et al. Demonstration of ATLV antigen in milk from three seropositive mothers. Gann 1984;75(2):103-5.
9. Khabbaz RF, Darrow WW, Hartley TM, et al. Seroprevalence and risk factors for HTLV-I/II infection among female prostitutes in the US.JAMA 1990;263:60-4.
10. Bartholomew C, Saxinger WC, Clark JW, Gail M, Dudgeon A, Mahabir B, et al. Transmission of HTLV-I and HIV among homosexual men in Trinidad. JAMA 1987;257(19):2605-8.
11. Sullivan MT, Williams AE, Fang CT, Grandinetti T, Poiesz BJ, Ehrlich GD. Transmission of HTLV types I and II by blood transfusion. A retrospective study of recipients of blood components (1983 to 1988). Arch Intern Med 1991;151(10):2043-8.
12. Okubo S. Pretransfusion screening tests for HIV and HTLV-in donated blood. Rinsho-Byori 1989;37(7):762-7. (Culled from English Abstract).
13. Hjelle B, Cyrus S, Sweason S, Miels R. Serologic distinction between Human T-Lymphotropic Virus type 1 (HTLV-I) and HTLV type II. Transfusion 1991;31(8):731-6.
14. Soriano V, Caldenron E, Cilla, Aguilere A, Merion F, Guitierrez M. Multicentre study of HTLV-I and II infection in Spain. Spanish Group for the Study of HTLV-I and II Infection. Med Clin Barc 1993;100(13):492-6. (Culled from English Abstract.)
15. Lamaire JM, Coste J, Barin F, Courouce M. Epidemiologic study of anti-HTLV-I and II antibodies in blood donors in Metropolitan France. Rev Fr Transfus Haemobiol 1991;34(1):21-34.
16. Dube DK, Dube S, Erensoy S, Jones B, Bryz-Gorniav, Spicer T, et al. Serological and nucleic acid analyses for HIV and HTLV Infection on archival human plasma samples from Zaire. Virology 1994;202(1):379-89.
17. Dumas M, Houinato D, Verdier M, Zohoun T, Josse R, Bonis J, et al. Seroepidemiology of HTLV-I/II in Benin (W Africa) AIDS Res Hum Retroviruses 1991;7(5):447-51.
18. Williams CK, Johnson AO, Blattaner WA. Human T-cell Leukaemia Virus in Africa: possible roles in health and disease. IARC Sci Pub 1984;(63)713-26.
19. Fleming AF, Yamamoto N, Bhsnurmath SR, Maharajan R, Schneider J, Hunsmann G. Antibodies to ATLV (HTLV) in Nigerian blood donors and patients with chronic lymphatic leukemia or lymphoma. Lancet Aug 6, 1983;334-5.
20. Fleming AF, Maharajan R, Abraham M, Kulkarni AG, Bhusnurmath SR, Okpara RA. Antibodies to HTLV-I in Nigerian blood donors, their relatives and patients with leukaemias, lymphomas and other diseases, Int J Cancer (Suppl) 1986;30:809-13.
21. Devesa SS, Fears T. Non-Hodgkin's lymphomas time trends: United States and International Data. Cancer Res (Suppl) 1992;52:5432-40.
22. Williams ME, Shipp MA, Hoppe RT. Hodgkin's Disease and non-Hodgkin's lymphoma: recent advances in the biology and epidemiology of NHL. In: Haematology 1993. Education Programme. Saint Louis: American Society of Haematology. 193:43-52.
23. Mann J, Tarantola DJM, Netter TW. The HIV pandemic: status and trends: HIV prevalence and incidence in specific populations: blood donors. In: AIDS in the world - a global report. Cambridge: Harvard University Press. 1992:6-68. Interactions of HIV and other diseases. 133-46.
24. Mann J, Tarantola DJM, Netter TW. The HIV pandemic: status and trends: HIV prevalence and incidence in specific populations: blood donors. In: AIDS in the world - a global report. Cambridge: Harvard University Press. 1992:6-68. Interactions of HIV and other diseases. 133-46.
25. Torrey, Muligan M, Way P. Blood donors and AIDS in Africa: the gift relationship revisited. US Bureau of the Census, Center for International Research. Staff Paper. No. 53, 1990.
26. Silber R, Stahl R. Chronic lymphocytic leukaemia and related diseases. In: William JW, editor. Hematology. 4th ed. New York: McGraw Hill. Comp. 1990. 1005-24.
27. Dada AJ, Oyewole F, Onofowokan R, Nasid A, Harris B, Levin A, et al. Demographic characteristics of retroviral infections (HIV-1, HIV-2 and HTLV-I) among female professional sex workers in Lagos, Nigeria. J Acquir Immun Defic Syndr 1993;6(12):1358-63.
28. Hunsman G, Bayer H, Schneider J, et al. Antibodies to ATLV/HTLV-I in Africa. Med Microbiol Immunol 1994;173:167-70.
29. Saxinger W, Blattner WA, Levine PH, Clark J, Biggar R, Hoh M, et al. HTLV-I antibodies in Africa. Science 1984;225:1473-6.
30. Houston S, Thornton C, Emmanuel J, Latif AS. Human T-Cell Lymphotropic Virus Type-I in Zimbabwe. Trans R Soc Med Hyg 1994;88(2):170-2.
31. Steele AD, Bos P, Jourbert JJ, Evans AC, Joseph S, Tucker I, et al. Low prevalence of HTLV-: type I in King San in Bushmanland, Namibia. Am J Trop Med Hyg 1994;51(4):460-5.
32. Sherman MP, Saksena NK, Dube DK, Yanagihara R, Poiesz BJ. Evolutionary insights on the origin of HTLV-I derived from sequence analysis of a new HTLV-I variant from Papua New Guinea. J Virol 1992;66(4):2556-63.
33. Hinuma Y, Komoda H, Chosa T, Kondo T, Kohakura M, Takenaka T, et al. Antibodies to Adult T-cell Leukaemia Virus-Associated Antigen (ATLA) in sera from patients with ATL and controls in Japan. A nationwide sero-epidemiologic study. Int J Cancer 1982;29(6):631-5.
34. Shimoyama M. Peripheral T-Cell Lymphoma in Japan. Recent progress. Ann Oncol 1991;Suppl.2:157-62.